145 related articles for article (PubMed ID: 14675893)
1. Workshop on secondary prevention of myocardial infarction and stroke and management of cardiovascular risk.
Mendis S
Anadolu Kardiyol Derg; 2003 Dec; 3(4):366-7. PubMed ID: 14675893
[No Abstract] [Full Text] [Related]
2. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
[TBL] [Abstract][Full Text] [Related]
3. WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE).
Mendis S; Abegunde D; Yusuf S; Ebrahim S; Shaper G; Ghannem H; Shengelia B
Bull World Health Organ; 2005 Nov; 83(11):820-9. PubMed ID: 16302038
[TBL] [Abstract][Full Text] [Related]
4. New WHO pocket-charts will save lives by predicting heart attack and stroke.
Cent Eur J Public Health; 2007 Dec; 15(4):146. PubMed ID: 18318046
[No Abstract] [Full Text] [Related]
5. The impact of the Canadian Hypertension Education Programme in its first decade.
McAlister FA; Feldman RD; Wyard K; Brant R; Campbell NR;
Eur Heart J; 2009 Jun; 30(12):1434-9. PubMed ID: 19454575
[No Abstract] [Full Text] [Related]
6. [What the MONICA project has taught us about cardiovascular diseases--society, public health and health care].
Asplund K; Eliasson M; Janlert U; Stegmayr B
Lakartidningen; 2006 Oct 4-10; 103(40):3006-11. PubMed ID: 17115672
[No Abstract] [Full Text] [Related]
7. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
[TBL] [Abstract][Full Text] [Related]
8. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials.
Saha SA; Molnar J; Arora RR
J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946
[TBL] [Abstract][Full Text] [Related]
9. Adherence, compliance, concordance, or the lack thereof.
DeMaria AN
J Am Coll Cardiol; 2012 Mar; 59(12):1120-1. PubMed ID: 22421308
[No Abstract] [Full Text] [Related]
10. Cardiology patient page. Heart attack and stroke prevention in women.
Becker RC
Circulation; 2005 Oct; 112(17):e273-5. PubMed ID: 16246950
[No Abstract] [Full Text] [Related]
11. Do all young ischemic stroke patients need long-term secondary preventive medication?
Naess H; Waje-Andreassen U; Thomassen L; Nyland H; Myhr KM
Neurology; 2005 Aug; 65(4):609-11. PubMed ID: 16116127
[TBL] [Abstract][Full Text] [Related]
12. Low-dose aspirin for primary prevention of cardiovascular disease.
Bredie SJ; Wollersheim H; Verheugt FW; Thien T
Semin Vasc Med; 2003 May; 3(2):177-84. PubMed ID: 15199480
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of myocardial infarction and stroke with statins].
Svilaas A; Kjeldsen SE; Midtbø K; Westheim A; Syvertsen JO
Tidsskr Nor Laegeforen; 2004 Jul; 124(13-14):1821. PubMed ID: 15229678
[No Abstract] [Full Text] [Related]
14. [Female, young, healthy. ASS does not protect from myocardial infarct].
MMW Fortschr Med; 2005 Mar; 147(12):10. PubMed ID: 15832782
[No Abstract] [Full Text] [Related]
15. Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke.
Muntner P; DeSalvo KB; Wildman RP; Raggi P; He J; Whelton PK
Am J Epidemiol; 2006 May; 163(10):913-20. PubMed ID: 16597707
[TBL] [Abstract][Full Text] [Related]
16. Saving costs using an ounce of prevention: introduction of a regional stroke prevention clinic.
Bisaillon S; Douen A; Neabel B; Pageau N; Selchen D
Axone; 2006; 27(3):29-33. PubMed ID: 16764405
[TBL] [Abstract][Full Text] [Related]
17. Stroke and heart attack prevention education.
Penney JB; Hahn JL
Medsurg Nurs; 1994 Dec; 3(6):459-64, 490. PubMed ID: 7874208
[TBL] [Abstract][Full Text] [Related]
18. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
[No Abstract] [Full Text] [Related]
19. The "Million Hearts" initiative--preventing heart attacks and strokes.
Frieden TR; Berwick DM
N Engl J Med; 2011 Sep; 365(13):e27. PubMed ID: 21913835
[No Abstract] [Full Text] [Related]
20. Achievement of secondary preventive goals after acute myocardial infarction: a comparison between participants and nonparticipants in a routine patient education program in Sweden.
Bellman C; Hambraeus K; Lindbäck J; Lindahl B
J Cardiovasc Nurs; 2009; 24(5):362-8. PubMed ID: 19652617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
